BridgeBio Pharma Inc Tangible Net Worth Ratio
BridgeBio Pharma Inc tangible net worth ratio. BridgeBio Pharma Inc (BBIO) has a Tangible Net Worth Ratio of 100.0% as of December 2020. This metric is calculated by deducting intangible assets ($0.00) from net assets ($107.89 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check strategic asset allocation of BridgeBio Pharma Inc to assess the company's strategic physical and investment asset allocation.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of BridgeBio Pharma Inc (2019–2020)
Tangible net worth ratio of BridgeBio Pharma Inc from 2019 to 2020. This chart shows how BridgeBio Pharma Inc's Tangible Net Worth Ratio has changed across 2 annual periods from 2019 to 2020. As of December 2020, the ratio stands at 100.0%, reflecting net assets of $107.89 Million with intangible assets of $0.00 USD. See BridgeBio Pharma Inc current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
BridgeBio Pharma Inc Tangible Net Worth Ratio by Year (2019–2020)
BridgeBio Pharma Inc tangible net worth ratio by year from 2019 to 2020. The table below presents the year-by-year Tangible Net Worth Ratio for BridgeBio Pharma Inc from 2019 to 2020, covering 2 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see BBIO market cap overview.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2020 | 100.0% | $107.89 Million | $0.00 | $703.59 Million | ▲ +0.0 pp |
| 2019 | 100.0% | $475.98 Million | $0.00 | $631.68 Million | — |